Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0023(+0.20%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
51,141.68
-747.10(-1.44%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

AstraZeneca PLC (AZN.ST)

Stockholm - Stockholm Real-time price. Currency in SEK

Add to watchlist

1,646.00

+4.50

(+0.27%)

At close: 05:29PM CEST

Currency in SEK

Valuation measures⁴

Market cap (intra-day)	2.53T
Enterprise value	2.82T
Trailing P/E	37.22
Forward P/E	17.89
PEG ratio (5-yr expected)	0.96
Price/sales (ttm)	4.95
Price/book (mrq)	6.24
Enterprise value/revenue	61.52
Enterprise value/EBITDA	209.98

Trading information

Stock price history

Beta (5Y monthly)	0.19
52-week change ³	8.64%
S&P500 52-week change ³	21.08%
52-week high ³	1,656.00
52-week low ³	1,261.00
50-day moving average ³	1,411.77
200-day moving average ³	1,420.62

Share statistics

Avg vol (3-month) ³	330.29k
Avg vol (10-day) ³	331.95k
Shares outstanding ⁵	1.55B
Implied shares outstanding ⁶	1.55B
Float ⁸	1.54B
% held by insiders ¹	0.18%
% held by institutions ¹	50.77%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	30.74
Forward annual dividend yield ⁴	1.87%
Trailing annual dividend rate ³	2.90
Trailing annual dividend yield ³	0.18%
5-year average dividend yield ⁴	2.48
Payout ratio ⁴	71.30%
Dividend date ³	N/A
Ex-dividend date ⁴	22 Feb 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	13.30%
Operating margin (ttm)	26.11%

Management effectiveness

Return on assets (ttm)	7.04%
Return on equity (ttm)	17.29%

Income statement

Revenue (ttm)	47.61B
Revenue per share (ttm)	30.74
Quarterly revenue growth (yoy)	16.50%
Gross profit (ttm)	N/A
EBITDA	15.8B
Net income avi to common (ttm)	6.33B
Diluted EPS (ttm)	44.16
Quarterly earnings growth (yoy)	20.90%

Balance sheet

Total cash (mrq)	8.02B
Total cash per share (mrq)	5.18
Total debt (mrq)	34.69B
Total debt/equity (mrq)	92.51%
Current ratio (mrq)	0.89
Book value per share (mrq)	24.17

Cash flow statement

Operating cash flow (ttm)	9.7B
Levered free cash flow (ttm)	8.68B